Hubert Schrezenmeier

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 16

Top Topics

Coronavirus Disease

Top Venues

Annals of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Johanna Veh, Carolin Ludwig, Hubert Schrezenmeier, Bernd Jahrsdörfer
Regulatory B Cells-Immunopathological and Prognostic Potential in Humans. Cells 13 (4) (2024)
Johanna Veh, Carolin Ludwig, Hubert Schrezenmeier, Bernd Jahrsdörfer
Regulatory B Cells-Immunopathological and Prognostic Potential in Humans. Cells 13 (4) (2024)
Johanna Veh, Carolin Ludwig, Hubert Schrezenmeier, Bernd Jahrsdörfer
Regulatory B Cells-Immunopathological and Prognostic Potential in Humans. Cells 13 (4) (2024)
Johanna Veh, Carolin Ludwig, Hubert Schrezenmeier, Bernd Jahrsdörfer
Regulatory B Cells-Immunopathological and Prognostic Potential in Humans. Cells 13 (4) (2024)
Maxime Desmarets, Simone Hoffmann, Charline Vauchy, Bart J A Rijnders, Eric Toussirot, Antoine Durrbach, Sixten Körper, Eva Schrezenmeier, C Ellen van der Schoot, Heli Harvala, Gaëlle Brunotte, Thomas Appl, Erhard Seifried, Pierre Tiberghien, Daniel Bradshaw, David J Roberts, Lise J Estcourt, Hubert Schrezenmeier
Early, very high-titre convalescent plasma therapy in clinically vulnerable individuals with mild COVID-19 (COVIC-19): protocol for a randomised, open-label trial. BMJ open 13 (4) (2023)
Maxime Desmarets, Simone Hoffmann, Charline Vauchy, Bart J A Rijnders, Eric Toussirot, Antoine Durrbach, Sixten Körper, Eva Schrezenmeier, C Ellen van der Schoot, Heli Harvala, Gaëlle Brunotte, Thomas Appl, Erhard Seifried, Pierre Tiberghien, Daniel Bradshaw, David J Roberts, Lise J Estcourt, Hubert Schrezenmeier
Early, very high-titre convalescent plasma therapy in clinically vulnerable individuals with mild COVID-19 (COVIC-19): protocol for a randomised, open-label trial. BMJ open 13 (4) (2023)
Maxime Desmarets, Simone Hoffmann, Charline Vauchy, Bart J A Rijnders, Eric Toussirot, Antoine Durrbach, Sixten Körper, Eva Schrezenmeier, C Ellen van der Schoot, Heli Harvala, Gaëlle Brunotte, Thomas Appl, Erhard Seifried, Pierre Tiberghien, Daniel Bradshaw, David J Roberts, Lise J Estcourt, Hubert Schrezenmeier
Early, very high-titre convalescent plasma therapy in clinically vulnerable individuals with mild COVID-19 (COVIC-19): protocol for a randomised, open-label trial. BMJ open 13 (4) (2023)
Hubert Schrezenmeier, Austin G Kulasekararaj, Lindsay Mitchell, Regis Peffault de Latour, Timothy Devos, Shinichiro Okamoto, Richard Wells, Evan Popoff, Antoinette Cheung, Alice Wang, Ioannis Tomazos, Yogesh Patel, Jong Wook Lee
Predictors for improvement in patient-reported outcomes: post hoc analysis of a phase 3 randomized, open-label study of eculizumab and ravulizumab in complement inhibitor-naive patients with paroxysmal nocturnal hemoglobinuria. Annals of hematology (2023)
Marco Mannes, Veronika Pechtl, Susanne Hafner, Arthur Dopler, Oskar Eriksson, Vivek Anand Manivel, Lisa Wohlgemuth, David Alexander Christian Messerer, Hubert Schrezenmeier, Kristina N Ekdahl, Bo Nilsson, Eva-Maria Jacobsen, Manfred Hoenig, Markus S Huber-Lang, Christian Karl Braun, Christoph Q Schmidt
Complement & platelets: Prothrombotic cell activation requires membrane attack complex induced release of danger signals. Blood advances (2023)
Maxime Desmarets, Simone Hoffmann, Charline Vauchy, Bart J A Rijnders, Eric Toussirot, Antoine Durrbach, Sixten Körper, Eva Schrezenmeier, C Ellen van der Schoot, Heli Harvala, Gaëlle Brunotte, Thomas Appl, Erhard Seifried, Pierre Tiberghien, Daniel Bradshaw, David J Roberts, Lise J Estcourt, Hubert Schrezenmeier
Early, very high-titre convalescent plasma therapy in clinically vulnerable individuals with mild COVID-19 (COVIC-19): protocol for a randomised, open-label trial. BMJ open 13 (4) (2023)
Maxime Desmarets, Simone Hoffmann, Charline Vauchy, Bart J A Rijnders, Eric Toussirot, Antoine Durrbach, Sixten Körper, Eva Schrezenmeier, C Ellen van der Schoot, Heli Harvala, Gaëlle Brunotte, Thomas Appl, Erhard Seifried, Pierre Tiberghien, Daniel Bradshaw, David J Roberts, Lise J Estcourt, Hubert Schrezenmeier
Early, very high-titre convalescent plasma therapy in clinically vulnerable individuals with mild COVID-19 (COVIC-19): protocol for a randomised, open-label trial. BMJ open 13 (4) (2023)
Lena Muckenthaler, Oriana Marques, Silvia Colucci, Joachim B Kunz, Piotr Fabrowski, Thomas Bast, Sandro Altamura, Britta Höchsmann, Hubert Schrezenmeier, Monika Langlotz, Paulina Richter-Pechanska, Tobias Rausch, Nicole Hofmeister-Mielke, Nikolas Gunkel, Matthias W Hentze, Andreas E Kulozik, Martina U Muckenthaler
Constitutional PIGA mutations cause a novel subtype of hemochromatosis in patients with neurologic dysfunction. Blood (2021)
Hector Rincon-Arevalo, Mira Choi, Ana Luisa Stefanski, Fabian Halleck, Ulrike Weber, Franziska Szelinski, Bernd Jahrsdörfer, Hubert Schrezenmeier, Carolin Ludwig, Arne Sattler, Katja Kotsch, Alexander Potekhin, Yidan Chen, Gerd-Rüdiger R Burmester, Kai Uwe Eckardt, Gabriela Maria Guerra, Pawel Durek, Frederik Heinrich, Marta Ferreira-Gomes, Andreas Radbruch, Klemens Budde, Andreia C Lino, Mir-Farzin Mashreghi, Eva Schrezenmeier, Thomas Dörner
Impaired humoral immunity to SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients and dialysis patients. Science immunology 6 (60) (2021)
Christoph Q Schmidt, Hubert Schrezenmeier, David Kavanagh
Complement and the prothrombotic state. Blood (2021)
Hubert Schrezenmeier, Alexander Röth, David J Araten, Yuzuru Kanakura, Loree Larratt, Jamile M Shammo, Amanda Wilson, Gilda Shayan, Jaroslaw P Maciejewski
Baseline clinical characteristics and disease burden in patients with paroxysmal nocturnal hemoglobinuria (PNH): updated analysis from the International PNH Registry. Annals of hematology 99 (7) (2020)
Cristina Manferdini, Francesca Paolella, Elena Gabusi, Luca Cattini, Markus T Rojewski, Hubert Schrezenmeier, Olga Addimanda, Riccardo Meliconi, Gina Lisignoli
Osteoarthritic Milieu Affects Adipose-Derived Mesenchymal Stromal Cells. Journal of orthopaedic research : official publication of the Orthopaedic Research Society 38 (2) (2019)